Beruflich Dokumente
Kultur Dokumente
The profit motive dictates that independent labs remain competitive with
an emphasis on innovation and efficiency. Technologies are constantly
changing and independent labs are generally better able to keep up with the
latest technological advances. In their thirdparty
position, these labs can also add product credibility via their independent
test results.
The traditional in-house laboratory normally is low on the list for budgetary
funds,impacting the corporate lab's performance. Essential, but expensive
to operate and often under-utilized -- this describes many traditional in-
house laboratories in the energy and petrochemical industries. The global
petrochemical industry alone spends more than $10 billion annually on
laboratory testing. The in-house lab can't deliver state-of-the-art testing,
which very often is what the parent corporation needs. The in-house
laboratory then becomes less useful to the parent corporation. A downward
spiral begins. In-house lab instruments are not replaced nor improved;
expertise and headcount are reduced to the point where the in-house
laboratory cannot meet corporate needs and falls below justifiable
utilization. The long-term future of the traditional in-house laboratory is
an open question.
What's driving the trend for Clinical trials outsourcing:
The United Kingdom, Europe and North America are leading the way, with
Australia, India, China and other locations close behind. Different regions
of the world, and certain countries within those regions, have differing
motivations for considering outsourcing, but they're all considering
outsourcing, Economic and investment reasons are prime reasons, but there
are other motivations to outsource the lab. For example, as former
Soviet Union countries enter global markets, cost savings are not driving lab
outsourcing. Instead they encounter issues related to international
recognition, international quality standards, need for technology and capital
investment. So they're looking to independent organizations to invest
capabilities, expertise and international standards required to become
accepted competitors in their global target markets.
pharmacogenomic Capabilities
• Wide range of genetic services performed in-house for optimal quality
and efficiency
• Sequencing analysis from tens of thousands of specimens used to
develop datasets and data resources for product development and
clinical management
• A wide variety of SNP analysis methodologies
• Assays such as CYP2D6, CYP2C19 and CYP2C9
• Custom SNP analysis available for sponsor-specific targets
• Platforms and technologies available for accurate detection of the
spectrum of mutations encountered in either human or microbial
genomes
• Resistance-testing program that screens patients using sponsors'
inclusion and exclusion criteria
• Innovative R&D capabilities that streamline the process of
developing an assay or transferring a technology to our laboratory
• Complete specimen archival and management for both short- and
long-term storage
• Dedicated, purpose-built Molecular Biology Laboratory:
Anatomic Pathology
A full range of Anatomic Pathology subspecialty expertise is available
from Ace laboratories Clinical Trials. You gain access to unsurpassed
in-house capabilities and some of the world's leading pathologists.
• Full range of services
• Routine testing and procedures
• Specialized testing and procedures
• Multiple specimen options
• Expert staffing
• Anatomic pathology
Cancer Testing
By working with the global leader in cancer diagnostics, you gain access
to a broad range of testing and information services in the detection,
diagnosis, evaluation and treatment of cancer, and related diseases
and medical conditions.
Our extensive diagnostics infrastructure includes over 100 doctors
and doctorate-level scientists providing services in our centers for
excellence and over 10 outpatient pathology laboratories.
Clinical trial elements
The success of any clinical development project depends on a sound
infrastructure and numerous critical key components that we call
“Clinical Trial Elements.” Each element is crucial to ensure your trials
are completed quickly and cost effectively. Partner with us to benefit
from our expertise in each of these specialist areas as part of a full-
service clinical development program, or use us to fulfill a single study
requirement. Whatever you need, we’re an ideal partner to complement
and fit alongside your own in-house capabilities
• tech tools
• Managing sites
• Medical know-how
• Protecting patients
• Medical writing
• Deliver
Clinical Services We out source
• Medical Affairs & Clinical Development Planning
• Interim management
• Clinical Operations
• Clinical Data Management, Biostatistics &
Statistical Programming
• Pharmacovigilance, Drug Safety & Medical
Information
• Regulatory Affairs
• Quality Assurance, GMP, GLP, GCP
• Laboratory
• Clinical Trial Supplie